Advancing Patient-Centric Care in Multiple Sclerosis: An Evidence-Based Guide for Appropriate Management with Current and Emerging Modalities

Advancing Patient-Centric Care in Multiple Sclerosis: An Evidence-Based Guide for Appropriate Management with Current and Emerging Modalities

On-Demand Webcast
Moderator

Robert P. Lisak, MD
Parker Webber Chair in Neurology
Professor of Neurology, Professor of Immunology and Microbiology
Wayne State University School of Medicine
Detroit, Michigan

Faculty Presenters

Bruce A. Cohen, MD
Professor, Davee Department of Neurology and Clinical Neurosciences
Northwestern University, Feinberg School of Medicine
Chicago, Illinois

Aaron E. Miller, MD
Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Professor of Neurology, Mt. Sinai School of Medicine
New York, New York

Learning Objectives

After completing this activity, participants should be able to:

  • Summarize safety and efficacy evidence for currently approved immunomodulatory agents used in the treatment of multiple sclerosis (MS)
  • Assess emerging clinical data for the use of oral MS therapies including mechanisms of action, efficacy, and adverse event profiles
  • Individualize MS therapy in clinical practice specific to individual patient needs and characteristics
Activity Overview

This on-demand webcast is available with synchronized video and slides

To be eligible for documentation of credit, participants complete the 10 question posttest and evaluation with a 70% passing score or higher. Participants who submit a completed evaluation will receive documentation of credit within 8 weeks. 

There is no fee associated with this activity.

Release date: December 31, 2012
Expiration date: December 31, 2013
Estimated time to complete: 1 hour

For questions regarding this educational activity, please call 609-371-1137.

Intended Learners

This activity is designed for neurologists and allied staff

Accreditation

In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE

This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

Independent Clinical Reviewer: Daniel Harrison, MD, Assistant Professor of Neurology, Johns Hopkins University School of Medicine, Baltimore Maryland

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Planning Committee

The planning committee compromises Bruce Cohen, MD, Robert Lisak, MD, Aaron Miller, MD, Susie Seaman, NP, Daniel Harrison, MD, Nick Lombardi, Michael Kearney, Kristen Petitto, Randy Robbin, Jessica Steuerman, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Lisak: Grant/research support—Teva, Avanir, Questcor, Novartis, sanofi-aventis, Roche, Biogen/idec, Genzyme, Genentec; Consultant—Teva, Questcor, Novartis; Advisory Boards: Teva, Questcor, Novartis; Expert Witness—Teva (patient cases)

Dr. Cohen: Grant/research support—Biogen-Idec, EMD-Serono, Novartis, Roche, Teva Neuroscience; Consultant—Accordia, Astellis, Biogen-Idec, EMD-Serono, Genzyme, sanofi-aventis, U.S., Teva Neuroscience; Stock shareholder —Abbott Laboratories, CVS-Caremark 

Dr. Miller: Grant/research support: Acorda, Biogen-Idec, Genentech, Genzyme, sanofi-aventis, Novartis, Roche; Consultant: Acorda, Biogen-Idec, Genzyme/sanofi-aventis, GlaxoSmith Kline, Merk Serono, Novartis, Nuron Biotech, ONO

Dr. Harrison: Grant/research support— Bayer Neuroscience

Ms. Seaman: Scientific advisor—Mölnlycke Health Care; Promotional speakers bureau—Mölnlycke

Mr. Lombardi:  Stock shareholder—Inspire Pharmaceuticals, Inc., ViroPharma, Inc., Vertex Pharmaceuticals

Mr. Kearney, Ms. Petitto, Mr. Robbin, Mr. Savage, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed in the presentations.

Hardware /Software Requirements

The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2012 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by an educational grant from Teva Pharmaceuticals